Acquired expression of OPN promotes enrichment and survival of leukemic stem cells (LSC) through the AKT/mTOR/PTEN/β-catenin/NF-κB signaling pathways in AML [212]. This evidence concerns the gene SPP1 and acute myeloid leukemia.